Page last updated: 2024-10-31

midazolam and Koch's Disease

midazolam has been researched along with Koch's Disease in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bansal, S1
Mittal, S1
Tiwari, P1
Jain, D1
Arava, S1
Hadda, V1
Mohan, A1
Malik, P1
Pandey, RM1
Khilnani, GC1
Guleria, R1
Madan, K1

Trials

1 trial available for midazolam and Koch's Disease

ArticleYear
Rigid Mini-Thoracoscopy Versus Semirigid Thoracoscopy in Undiagnosed Exudative Pleural Effusion: The MINT Randomized Controlled Trial.
    Journal of bronchology & interventional pulmonology, 2020, Volume: 27, Issue:3

    Topics: Adult; Analgesics, Opioid; Biopsy; Exudates and Transudates; Female; Fentanyl; Humans; Hypnotics and

2020